The estradiol/oocyte ratio predicts the MII oocyte rate, but not live‐birth rate in a depot gonadotropin‐releasing hormone agonist long protocol
Authors:
- 11 October 2020
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 153 (1) , 100-105
Abstract
Objective: To investigate whether the estradiol/oocyte ratio (E 2 /O) can predict ovarian response and pregnancy outcomes. Methods: This is a retrospective cohort study on 1838 individuals undergoing in vitro fertilization with a depot gonadotropin‐releasing hormone agonist (GnRH‐a) long protocol. The patients were grouped by the quartiles of E 2 /O: 242.9 pg/mL. ANOVA and χ 2 test with the Bonferroni adjustment were used for statistical analysis. Results: With the rise of E 2 /O, the MII oocyte rate increased, whereas the number of oocytes retrieved decreased. The number of MII oocytes, fertilization rate, and the number of high‐grade embryos were similar among the four groups. There were no differences in live‐birth rate, clinical pregnancy rate, ectopic pregnancy rate, and miscarriage rate, but there was a trend towards a higher miscarriage rate in the patients with E 2 /O between 131.2 and 242.9 pg/mL. Conclusion: E 2 /O indicates the percentage of MII oocytes, but not the quality of an individual follicle. E 2 /O does not predict live birth in a depot GnRH‐a long protocol; however, there is a trend towards a higher risk for miscarriage in the patients with E 2 /O between 131.2 and 242.9 pg/mL.Keywords
This publication has 18 references indexed in Scilit:
- Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo TransferCurrent Medical Science, 2019
- The effect of serum vitamin D levels in couples on embryo development and clinical outcomesReproductive BioMedicine Online, 2019
- IntroductionFertility and Sterility, 2017
- Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovaryHuman Reproduction Update, 2016
- The criteria for optimal down-regulation with gonadotropin-releasing hormone-agonist: a retrospective cohort studyGynecological Endocrinology, 2015
- Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?Fertility and Sterility, 2014
- Can serum oestradiol be a predictor of quality of oocytes and embryos, maturation of oocytes and pregnancy rate in ICSI cycles?Gynecological Endocrinology, 2010
- Area Under the Curve for Estradiol Levels Do Not Consistently Reflect Estradiol Levels on the Day of hCG Administration in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF-ETJournal of Assisted Reproduction and Genetics, 2005
- The role of estrogen in folliculogenesisMolecular and Cellular Endocrinology, 1999
- Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potentialThe Journal of Clinical Endocrinology & Metabolism, 1995